Showing 9171-9180 of 21415 results for "".
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/unmet-needs-nsclc/49143/Advances in targeted therapies have dramatically improved outcomes for patients with ALK-positive non-small cell lung cancer, but new resistance challenges continue to emerge. In this episode, Dr. Urs Weber discusses how cancers adapt to treatment, why off-target resistance and histologic transformaINTEGUMENT-OLE and What’s Next for Pediatric AD
https://reachmd.com/videos/skin-minute/integument-ole-study/56899/Pediatric dermatologist Larry Eichenfield, MD, talks about the INTEGUMENT-OLE study data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate atopic dermatitis in children aged 2 to 5 years.Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
https://reachmd.com/programs/living-rheum/preventing-sjogrens-complications-the-importance-of-timely-accurate-diagnosis/36347/Delayed recognition of Sjögren’s disease can lead to serious complications, including interstitial lung disease, lymphoma, and renal involvement. That's why awareness of these diverse manifestations can improve diagnostic accuracy, prevent irreversible damage, and support timely, comprehensive care.Rethinking Lupus Nephritis: Targeting Immune Dysfunction
https://reachmd.com/programs/living-rheum/rethinking-lupus-nephritis-targeting-immune-dysfunction/32819/Despite common misconceptions, lupus nephritis is part of a broader immune imbalance seen in systemic lupus, not a separate condition. This is why it's important to shift focus from organ-specific treatment to immune dysregulation targeting. Hear Dr. Joan Merrill, Professor at the Oklahoma Medical RBeyond the Stiff Neck: Meningitis Detection in Infants and Toddlers
https://reachmd.com/programs/clinicians-roundtable/beyond-the-stiff-neck-meningitis-detection-in-infants-and-toddlers/37110/Despite the success of meningitis vaccination programs, pediatricians must remain vigilant as cases still occur and can be life-threatening if missed. That’s why Dr. Jessica Snowden joins us to share how we can identify subtle behavioral cues, understand age-specific presentations, and diagnose patiEpithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
https://reachmd.com/programs/living-rheum/epithelial-cell-activation-in-sjogrens-a-new-target-in-chronic-inflammation/36341/New research into primary Sjögren’s disease reveals how epithelial cells may actively drive chronic inflammation through gene-level changes. In this AudioAbstract, Ryan Quigley walks through the findings from an in vitro study examining the effects of prolonged interferon gamma exposure on salivaryAcne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
https://reachmd.com/programs/dermconsult/acne-eczema-and-psoriasis-improving-treatment-adherence-in-younger-patients/35502/When treating adolescents and young adults with acne, eczema, and psoriasis, getting them to adhere to their regimen may be difficult. However, practical strategies like explaining the therapy and its side effects and encouraging patients to set reminders can help them stay on track and optimize theUpdates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
https://reachmd.com/programs/neurofrontiers/updates-from-mint-inebilizumab-reduces-relapses-and-rescue-therapy-use/35869/After the primary findings from the Myasthenia Gravis Inebilizumab Trial (MINT) demonstrated the clinical benefit and safety of inebilizumab for patients with generalized myasthenia gravis (gMG), a secondary analysis evaluated inebilizumab’s impact on exacerbation rates and the need for rescue theraHow Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
https://reachmd.com/programs/neurofrontiers/how-diagnostic-delays-in-gmg-impact-disease-severity-outcomes-and-quality-of-life/35492/The symptom variability, prolonged asymptomatic periods, and inconsistent presentations of generalized myasthenia gravis (gMG) often lead to significant diagnostic delays and misdiagnoses. Based on recent studies, these delays then correlate with increased disease severity, longer time to symptom coQuality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
https://reachmd.com/programs/neurofrontiers/quality-of-life-challenges-in-gmg-care-navigating-the-invisible-burden/35493/Generalized myasthenia gravis (gMG) presents with highly variable symptoms that can significantly impact a patient’s quality of life, often in ways that are invisible to others. That’s why Dr. Maxwell Levy joins us to discuss these unmet needs and how we can address them with various clinical strate